MedPath

iLab Co., Ltd

🇰🇷South Korea
Ownership
Holding
Employees
-
Market Cap
-
Website
http://www.ilab.co.kr

Clinical Trials

4

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (100.0%)

MAD Study of IA-14069

Phase 1
Recruiting
Conditions
Healthy
Rheumatoid Arthritis
Interventions
First Posted Date
2022-09-09
Last Posted Date
2025-05-20
Lead Sponsor
ILAb Co., Ltd.
Target Recruit Count
75
Registration Number
NCT05533372
Locations
🇺🇸

ICON plc., Lenexa, Kansas, United States

SAD Study of IA-14069

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2022-04-08
Last Posted Date
2023-01-04
Lead Sponsor
ILAb Co., Ltd.
Target Recruit Count
40
Registration Number
NCT05317741
Locations
🇺🇸

ICON plc., Lenexa, Kansas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.